SB 665 New Hampshire Senate · 2026 Regular Session

relative to pharmacy benefits managers, managed care laws, notice of drug pricing options and pharmacy benefit manager business practices.

SB 665 requires pharmacies to charge consumers the lowest available price for prescription drugs at the point of sale, directly affecting patients purchasing medications and pharmacies. The bill defines "lowest available price" as the minimum of the pharmacy’s cash price, the consumer’s insurance cost-sharing amount, or any available discount price at the time of transaction. Pharmacists must determine and disclose this price before completing the sale, and insurers cannot penalize pharmacies for doing so. Violations could result in disciplinary action by the pharmacy board or civil penalties up to $1,000 per violation, with the law taking effect January 1, 2027.
Bill status failed 3 of 5 stages cleared
Introduction
Feb 2026
Committee Review
May 2026
Senate Passage
Mar 2026
House Passage
Governor
Introduced Feb 4, 2026 Last action May 14, 2026
Maddy AI version diff · 1 comparison

What changed between versions

Introduced As Amended by the Senate · 6 edits
MODERATE
The bill was completely transformed from a consumer protection measure requiring pharmacies to charge the lowest available price for prescription drugs into a PBM regulation bill focused on written agreements, reporting requirements, and increased penalties for pharmacy benefits managers. The original mandate that pharmacists must determine and charge the lowest price at point of sale was removed and replaced with a much weaker requirement that pharmacies merely notify consumers of their right to request the lowest price. The amended bill shifts regulatory authority from the Pharmacy Board (RSA 318) to the Insurance Department's PBM chapter (RSA 402-N).
SCOPE

The bill's entire focus shifted from requiring pharmacies to charge consumers the lowest available price for prescription drugs to regulating pharmacy benefits managers through written agreements, reporting requirements, and increased penalties. The title changed from 'requiring pharmacies to charge consumers the lowest available price' to 'relative to pharmacy benefits managers, managed care laws, notice of drug pricing options and pharmacy benefit manager business practices.'

REQUIREMENT

The original requirement that pharmacists must determine and charge the lowest available price at point of sale (comparing retail price, insurance cost-sharing, and discount prices) was removed entirely. The original also required documenting when a consumer chose insurance over a lower cash or discount price.

A new section (RSA 402-N:2-a) requires PBMs to have written agreements with health carriers before operating. These agreements must include a statement of duties, a fiduciary duty clause, a books and records requirement, and instructions for performing delegated duties. Health carriers must conduct semi-annual on-site or virtual audits when a PBM administers benefits for more than 100 covered lives in New Hampshire.

PBMs must now submit semi-annual reports to the Insurance Commissioner listing all health benefit plans they administer and the rebates collected from pharmaceutical manufacturers attributable to patient utilization in New Hampshire, including aggregate dollar amounts spent on drugs prior to rebates.

ENFORCEMENT

The maximum administrative fine for PBM violations was increased from $2,500 per violation to $10,000 per violation, with each day of non-compliance now counted as a separate violation. The original bill's $1,000 penalty through the Pharmacy Board was removed.

DEFINITION

The definition of 'pharmacy benefits manager' in RSA 402-N:1 was expanded to explicitly include wholly or partially owned or controlled subsidiaries of a PBM or licensed health insurer. The previous exclusion for health insurers providing PBM services exclusively to their own insureds was removed.

Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
18
Key actions
7
Committee
8
Amendments
2
May 1, 2026
Lower · Passed
Minority Committee Report: Ought to Pass with Amendment # 2026-1758h
lower
May 1, 2026
Committee
Majority Committee Report: Inexpedient to Legislate 04/29/2026 (Vote 13-2; RC) HC 19 P. 17
lower
Apr 22, 2026
Lower · Passed
Subcommittee Work Session: 04/28/2026 10:00 am GP 229
lower
Apr 16, 2026
Lower · Passed
Subcommittee Work Session: 04/22/2026 10:00 am GP 229
lower
Mar 27, 2026
Introduced
Introduced (in recess of) 03/26/2026 and referred to Commerce and Consumer Affairs HJ 9 P. 55
lower
Mar 26, 2026
Upper · Passed
Ought to Pass with Amendments #2026-1047s, and #2026-1239s and #2026-1129s, RC 24Y-0N, MA; OT3rdg; 03/26/2026; SJ 7
upper
Mar 26, 2026
Introduced
Sen. Rosenwald Floor Amendment # 2026-1129s, AA, VV; 03/26/2026; SJ 7
upper
Mar 26, 2026
Introduced
Sen. Ricciardi Floor Amendment # 2026-1239s, AA, VV; 03/26/2026; SJ 7
upper
Mar 26, 2026
Upper · Passed
Committee Amendment # 2026-1047s, AA, VV; 03/26/2026; SJ 7
upper
Mar 12, 2026
Upper · Passed
Committee Report: Ought to Pass with Amendment # 2026-1047s, 03/26/2026, Vote 5-0; SC 11
upper
Mar 5, 2026
Upper · Passed
Committee Report: Ought to Pass with Amendment # 2026-1047s, 03/12/2026; Vote 5-0; CC; SC 9
upper
Feb 4, 2026
Introduced
Introduced 01/29/2026 and Referred to Health and Human Services; SJ 3
upper
1 primary · 16 co-sponsors

Sponsors